Next Article in Journal / Special Issue
The Role of Cannabinoid Receptors in the Descending Modulation of Pain
Previous Article in Journal
Pharmacogenetics of Anti-Diabetes Drugs
Previous Article in Special Issue
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
Pharmaceuticals 2010, 3(8), 2647-2660; doi:10.3390/ph3082647
Review

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism

1, 2, 1 and 2,*
Received: 13 July 2010; in revised form: 6 August 2010 / Accepted: 11 August 2010 / Published: 13 August 2010
(This article belongs to the Special Issue Cannabinoids)
View Full-Text   |   Download PDF [252 KB, uploaded 13 August 2010]   |   Browse Figures
Abstract: Phytocannabinoids present in Cannabis plants are well known to exert potent anti-inflammatory and immunomodulatory effects. Previously, we have demonstrated that the psychoactive D9-tetrahydrocannabinol (THC) and the non-psychotropic cannabidiol (CBD) modulate mitogen-induced Th1-type immune responses in peripheral blood mononuclear cells (PBMC). The suppressive effect of both cannabinoids on mitogen-induced tryptophan degradation mediated by indoleamine-2,3-dioxygenase (IDO), suggests an additional mechanism by which antidepressive effects of cannabinoids might be linked to the serotonergic system. Here, we will review the role of tryptophan metabolism in the course of cell mediated immune responses and the relevance of cannabinoids in serotonergic signaling. We conclude that in particular the non-psychotropic CBD might be useful for the treatment of mood disorders in patients with inflammatory diseases, since this cannabinoid seems to be safe and its effects on activation-induced tryptophan degradation by CBD were more potent as compared to THC.
Keywords: tryptophan; indoleamine-2,3-dioxygenase; Δ9-tetrahydrocannabinol; cannabidiol tryptophan; indoleamine-2,3-dioxygenase; Δ9-tetrahydrocannabinol; cannabidiol
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Jenny, M.; Schröcksnadel, S.; Überall, F.; Fuchs, D. The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. Pharmaceuticals 2010, 3, 2647-2660.

AMA Style

Jenny M, Schröcksnadel S, Überall F, Fuchs D. The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. Pharmaceuticals. 2010; 3(8):2647-2660.

Chicago/Turabian Style

Jenny, Marcel; Schröcksnadel, Sebastian; Überall, Florian; Fuchs, Dietmar. 2010. "The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism." Pharmaceuticals 3, no. 8: 2647-2660.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert